Matches in DBpedia 2015-10 for { <http://dbpedia.org/resource/Satavaptan> ?p ?o }
Showing triples 1 to 76 of
76
with 100 triples per page.
- Satavaptan abstract "Satavaptan (INN; codenamed SR121463, planned tradename Aquilda) is a vasopressin-2 receptor antagonist undergoing research for the treatment of hyponatremia. It is also being studied for the treatment of ascites.It was developed by Sanofi-Aventis. As of 2008, it is under regulatory review in the European Union.".
- Satavaptan atcPrefix "none".
- Satavaptan casNumber "185913-78-4".
- Satavaptan fdaUniiCode "AJS8S3P31H".
- Satavaptan iupacName "N-(tert-butyl)-4-{[(1s,4s)-5'-ethoxy-4-(2-morpholin-4-ylethoxy)-2'-oxospiro[cyclohexane-1,3'-indol]-1'(2'H)-yl]sulfonyl}-3-methoxybenzamide".
- Satavaptan pubchem "9810773".
- Satavaptan thumbnail Satavaptan_structure.svg?width=300.
- Satavaptan wikiPageID "18065584".
- Satavaptan wikiPageLength "3240".
- Satavaptan wikiPageOutDegree "9".
- Satavaptan wikiPageRevisionID "673325118".
- Satavaptan wikiPageWikiLink Ascites.
- Satavaptan wikiPageWikiLink Category:Diuretics.
- Satavaptan wikiPageWikiLink Category:Hormonal_agents.
- Satavaptan wikiPageWikiLink Category:Vasopressin_receptor_antagonists.
- Satavaptan wikiPageWikiLink European_Union.
- Satavaptan wikiPageWikiLink Hyponatremia.
- Satavaptan wikiPageWikiLink International_Nonproprietary_Name.
- Satavaptan wikiPageWikiLink Sanofi.
- Satavaptan wikiPageWikiLink Sanofi-Aventis.
- Satavaptan wikiPageWikiLink Vasopressin_receptor_antagonist.
- Satavaptan wikiPageWikiLinkText "Satavaptan".
- Satavaptan wikiPageWikiLinkText "satavaptan".
- Satavaptan atcPrefix "none".
- Satavaptan c "33".
- Satavaptan casNumber "185913".
- Satavaptan chemspiderid "32699105".
- Satavaptan h "45".
- Satavaptan hasPhotoCollection Satavaptan.
- Satavaptan inchi "1".
- Satavaptan inchikey "QKXJWFOKVQWEDZ-VCCCEUOBBM".
- Satavaptan iupacName "N--4-{[-5'-ethoxy-4--2'-oxospiro[cyclohexane-1,3'-indol]-1'-yl]sulfonyl}-3-methoxybenzamide".
- Satavaptan molecularWeight "643.789".
- Satavaptan n "3".
- Satavaptan o "8".
- Satavaptan pubchem "9810773".
- Satavaptan s "1".
- Satavaptan smiles "CCOc1cc2cNSc5cOC CCOc1cc2cNSc5cOC".
- Satavaptan stdinchi "1".
- Satavaptan stdinchikey "QKXJWFOKVQWEDZ-VCCCEUOBSA-N".
- Satavaptan unii "AJS8S3P31H".
- Satavaptan verifiedfields "changed".
- Satavaptan verifiedrevid "455169440".
- Satavaptan width "280".
- Satavaptan wikiPageUsesTemplate Template:Cardiovascular-drug-stub.
- Satavaptan wikiPageUsesTemplate Template:Diuretics.
- Satavaptan wikiPageUsesTemplate Template:Drugbox.
- Satavaptan wikiPageUsesTemplate Template:Neuropeptidergics.
- Satavaptan wikiPageUsesTemplate Template:Reflist.
- Satavaptan subject Category:Diuretics.
- Satavaptan subject Category:Hormonal_agents.
- Satavaptan subject Category:Vasopressin_receptor_antagonists.
- Satavaptan hypernym Antagonist.
- Satavaptan type Agent.
- Satavaptan type Article.
- Satavaptan type ChemicalSubstance.
- Satavaptan type Drug.
- Satavaptan type Agent.
- Satavaptan type Article.
- Satavaptan type Chemical.
- Satavaptan type Diuretic.
- Satavaptan type Drug.
- Satavaptan type Preparation.
- Satavaptan type ChemicalObject.
- Satavaptan type Thing.
- Satavaptan type Q8386.
- Satavaptan comment "Satavaptan (INN; codenamed SR121463, planned tradename Aquilda) is a vasopressin-2 receptor antagonist undergoing research for the treatment of hyponatremia. It is also being studied for the treatment of ascites.It was developed by Sanofi-Aventis. As of 2008, it is under regulatory review in the European Union.".
- Satavaptan label "Satavaptan".
- Satavaptan sameAs m.047mr0k.
- Satavaptan sameAs Satavaptan.
- Satavaptan sameAs Satavaptan.
- Satavaptan sameAs Q7425965.
- Satavaptan sameAs Q7425965.
- Satavaptan wasDerivedFrom Satavaptan?oldid=673325118.
- Satavaptan depiction Satavaptan_structure.svg.
- Satavaptan isPrimaryTopicOf Satavaptan.